Abstract
Interleukin-7 (IL-7) plays a key role in maturation and function of both T and B cells. We investigate the potential use of recombinant human IL-7 for facilitation of graft-versus-leukemia (GVL) effects mediated by T cells following transplantation in a murine model. Administration of IL-7 in vivo to allogeneic-transplanted mice improved disease-free survival: 67% of mice treated with IL-7 remained alive and disease free for more than 60 days, in comparison to 17% of the controls (P<0.05). Similar results were obtained when C57BL/6 spleen cells sensitized against irradiated B-cell leukemia (BCL1) cells in the presence of IL-7 were transplanted to F1 mice, followed by IL-7 treatment in vivo. Of the BALB/c mice that received spleen cells from F1 mice treated with IL-7 following transplantation of C57BL/6 spleen cells sensitized with irradiated BCL1 in the presence of IL-7, only 29% developed leukemia, as compared to 79% in the control group (P<0.05). Mice treated with IL-7 showed increased splenic and thymic cellularity and improved T cell-dependent proliferative responses compared to the controls (P<0.05). IL-7 may provide a novel tool to enhance immune reconstitution following transplantation of mismatched stem cells and for enhancement of GVL effects mediated by alloreactive lymphocytes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Truitt R, Johnson B, McCabe C, Weiler M . Graft-versus-leukemia. In: Ferrara J, Deeg H, Bukaroff S (eds). Graft-vs-Host Disease, 2nd edn. Marcel Dekker Inc.: New York, 1997, pp 385–424.
Barnes DHW, Loutit JF . Treatment of murine leukaemia with x-rays and homologous bone marrow. II. Br J Haematol 1957; 3: 241–252.
Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M, Devries MJ et al. Successful allogeneic bone marrow transplantation in man: chimerism, induced specific tolerance and possible antileukemic effects. Blood 1965; 25: 179.
Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED . Anti-leukemic effect of chronic graft-versus-host-disease: contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529–1531.
Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562.
Fry TJ, Mackall CL . Interleukin-7: from bench to clinic. Blood 2002; 99: 3892–3904.
Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF . T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol Immunol 2002; 38: 841–848.
Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K . Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996; 88: 1887–1894.
Okamoto Y, Douek DC, McFarland RD, Koup RA . Effects of exogenous interleukin-7 on human thymus function. Blood 2002; 99: 2851–2858.
Geiselhart LA, Humphries CA, Gregorio TA, Mou S, Subleski J, Komschlies KL . IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J Immunol 2001; 166: 3019–3027.
Lynch DH, Miller RE . Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J Exp Med 1994; 179: 31–42.
Wiryana P, Bui T, Faltynek CR, Ho RJ . Augmentation of cell-mediated immunotherapy against herpes simplex virus by interleukins: comparison of in vivo effects of IL-2 and IL-7 on adoptively transferred T cells. Vaccine 1997; 15: 561–563.
Abdul-Hai A, Or R, Slavin S, Friedman G, Weiss L, Matsa D et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol 1996; 24: 1416–1422.
Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, Rotolo JA et al. Administration of interleukin-7 after allogeneic bone marrow improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001; 98: 2256–2265.
Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE . IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001; 97: 1491–1497.
Slavin S, Strober S . Spontaneous murine B-cell leukaemia. Nature 1978; 272: 624–626.
Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186–1193.
Aversa F, Velardi A, Tabilio A, Reisner Y, Martelli MF . Haploidentical stem cell transplantation in leukemia. Blood Rev 2001; 15: 111–119.
Or R, Abdul-Hai A, Ben-Yehuda A . Reviewing the potential utility of interleukin-7 as a promoter of thymopoiesis and immune recovery. Cytokines Cell Mol Ther 1998; 4: 287–294; Review.
Abdul-Hai A, Weiss L, Slavin S, Or R . Improved survival following induction of GVHD following lipopolysaccharide immunization. Exp Hematol 2006; 34: 549–553.
Weiss L, Reich S, Slavin S . Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia. Cytokines Cell Mol Ther 1999; 5: 153–158.
Acknowledgements
We thank the Danny Cunniff Leukemia Research Laboratory for its continuous support of our ongoing basic and clinical research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdul-Hai, A., Weiss, L., Ben-Yehuda, A. et al. Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1). Bone Marrow Transplant 40, 881–889 (2007). https://doi.org/10.1038/sj.bmt.1705819
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705819
Keywords
This article is cited by
-
Interleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation
Journal of Hematology & Oncology (2017)